1Mitsuhiro Tada,Yutaka Sawamura,Shirou Sakuma,Kazuo Suzuki,Hidemi Ohta,Toshimitsu Aida,Hiroshi Abe. Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor α for the treatment of malignant gliomas[J] 1993,Cancer Immunology Immunotherapy(4):251～259
2Riks A. Maas,Hub F. J. Dullens,Willem Otter. Interleukin-2 in cancer treatment: Disappointing or (still) promising? A review[J] 1993,Cancer Immunology Immunotherapy(3):141～148
3Randall E. Merchant,Daniel W. McVicar,Lynn H. Merchant,Harold F. Young. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-α. Results of a phase I clinical trial[J] 1992,Journal of Neuro - Oncology(1):75～83
